Covid-19 vaccines

The Qraft AI-Enhanced US Large Cap Momentum ETF (NYSE: AMOM), an exchange-traded fund driven by artificial intelligence, has acquired stakes in PayPal Holdings Inc. (NASDAQ: PYPL), Intel Corp. (NASDAQ: INTC) and Moderna Inc. (NASDAQ: MRNA), while entirely divesting its holdings in Amazon.com Inc. (...

After a protracted delay, Novavax, Inc. (NASDAQ: NVAX) is finally making some headway with its COVID-19 vaccine candidate – NVXCoV2373. What Happened: Maryland-based Novavax said it has completed its rolling regulatory submission to the U.K. Medicines and Healthcare products Regulatory...

Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) fell 2% in Tuesday’s regular trading session after seeing strong gains on Monday. What Happened: Ocugen’s stock fell more than 2% to $9.15 in Tuesday’s trading on disappointing news related to Covaxin, the COVID-19...

Shares of Ocugen Inc. (NASDAQ: OCGN) surged almost 12.3% in Monday’s regular trading session and another 38.5% in the after-hours session in anticipation of a key event taking place Tuesday. What Happened: Ocugen's shares saw notable gains on Monday ahead of a key meeting on...

The U.S. Food and Drug Administration on Wednesday approved booster shots of Moderna Inc.’s (NASDAQ: MRNA) and Jonson & Johnson’s (NYSE: JNJ) COVID-19 vaccines as well as authorized “mixing and matching” of the booster doses. What Happened: The FDA said it has approved...

Moderna Inc (NASDAQ: MRNA) does not plan to share the formula for making its COVID-19 vaccine, Chairman Noubar Afeyan said in a recent interview with the Associated Press. What Happened: Afeyan told the Press that Moderna executives have come to the conclusion that ramping up production is the best...

Shares of biopharmaceutical company Ocugen Inc. (NASDAQ: OCGN) surged almost 8.8% in Monday’s regular trading session and also gained 11.4% in the after-hours session. What Happened: Ocugen’s shares rallied on Monday despite no company-specific news. The stock could have gained amid...

Pfizer Inc (NYSE: PFE) expects to apply for U.S. authorization of its COVID-19 vaccine for children aged six months and five years in November, the Financial Times reported. What Happened: Pfizer Chief Financial Officer Frank D’Amelio told an industry conference organized by Morgan...

Cathie Wood-led Ark Invest on Tuesday sharply reduced its exposure in Boeing Co (NYSE: BA) a day after European budget airline Ryanair Holdings Plc (NASDAQ: RYAAY) called off talks with the planemaker for a potential 737 MAX 10 jet order, worth billions of dollars, due to differences over pricing....

There has been no dearth of interesting news from the technology, cryptocurrency and corporate sectors despite the long Labor Day weekend. Here is a quick roundup of the top five stories that investors may have missed. 1. El Salvador Buys Bitcoin Ahead Of Making It Legal Lender: Bitcoin (...

Cathie Wood’s Ark Invest now holds just about 700 shares in Alibaba Group Holding (NYSE: BABA) after the money managing firm on Wednesday further reduced its exposure in the e-commerce giant. Ark Invest sold 3,626 shares — estimated to be worth about $628,313 — in Alibaba, as...

Moderna Inc (NASDAQ: MRNA) is pushing ahead for authorization of a third shot of its COVID-19 vaccine as a booster. What Happened: The Massachusetts-based company said in a statement Wednesday that it had initiated its submission to the U.S. Food and Drug Administration for evaluation of a booster...

Walmart Inc (NYSE: WMT) has stated its readiness to administer millions of COVID-19 booster vaccine doses in 2021 fall once recommended by the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA). The company has joined the likes of CVS Health...

Cathie Wood-led investment firm Ark Invest on Monday snapped up shares in 3D Systems Corp (NYSE: DDD) and Nano Dimension Ltd (NASDAQ: NNDM), further lifting its exposure in the 3D printing sector. Ark Invest bought 138,600 shares — estimated to be worth about $4.18 million — in 3D...

Moderna Inc (NASDAQ: MRNA) shares closed almost 3% lower in the regular session on Monday. What’s Moving? The decline in Moderna shares comes as the U.S. Centers for Disease Control and Prevention explores if a third shot of the COVID-19 vaccine should be provided to the masses. On Monday,...